Feed BRIBF
BR
Brii Biosciences Limited
BRIBF · OTC
$0.13 +0.00% (+$0.00)
1M -10.84%
Market Cap ¥632.7M
P/E Ratio -
Div. Yield -
ROE 8.36%
Bulios Fair Price
$0.07
46.2% downside
Current Price
$0.13
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BRIBF is currently overvalued relative to its market price. How does it work?
Valuation
50 /100
Fair P/B 0.27x
P/S 34.91x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 9.39%
Rev. growth 29.45%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 1,632.59%
Gross margin 0.00%
FCF margin 1,591.41%
Quality
0 /100
Poor ROA 9.19%
ROIC 12.79%
Asset turnover 0.01x
Debt
69 /100
Low Int. coverage -154.89x
Debt/Equity 0.00x
Current ratio 60.73x
Stability
15 /100
Unstable EPS volatility 145.72%
Beta 1.24x
Profitable years 0
Ask StockBot about BRIBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zhi Hong
Employees
75
Headquarters
Beijing
Upcoming events
20 AUG
Earnings
Upcoming earnings report